Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 10 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Ani Pharmaceuticals Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- +7 vs. Q2 2022
- Shares held
- 10.3M
- +390.2K (+3.9%) vs. Q2 2022
- Total value
- $330.3M
- +$36.9M (+12.6%) vs. Q2 2022
- New holders
- 17
- 33 more added
- Sold out
- 10
- 50 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 307 | $1.90B |
| Q1 2026 | 281 | $1.80B |
| Q4 2025 | 285 | $1.67B |
| Q3 2025 | 269 | $1.87B |
| Q2 2025 | 233 | $1.29B |
| Q1 2025 | 231 | $1.34B |
| Q4 2024 | 206 | $1.07B |
| Q3 2024 | 208 | $1.12B |
| Q2 2024 | 201 | $962.3M |
| Q1 2024 | 200 | $975.2M |
| Q4 2023 | 181 | $750.8M |
| Q3 2023 | 186 | $766.4M |
| Q2 2023 | 172 | $662.5M |
| Q1 2023 | 138 | $411.7M |
| Q4 2022 | 126 | $412.4M |
| Q3 2022 | 126 | $330.3M |
| Q2 2022 | 120 | $293.4M |
| Q1 2022 | 126 | $258.8M |
| Q4 2021 | 132 | $413.4M |
| Q3 2021 | 118 | $238.8M |
| Q2 2021 | 116 | $252.7M |
| Q1 2021 | 106 | $263.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Goldman Sachs Group Inc | 92,626 | $2.98M | 0.00% | −43,183−31.8% | Reduced |
| Tang Capital Management LLC | 100,000 | $3.21M | 0.39% | 00.0% | Unchanged |
| Brandywine Global Investment Management, LLC | 109,735 | $3.53M | 0.03% | +22,138+25.3% | Added |
| Parkman Healthcare Partners LLC | 117,941 | $3.79M | 1.08% | +9,382+8.6% | Added |
| Ranger Investment Management, L.P. | 118,510 | $3.81M | 0.30% | −2,131−1.8% | Reduced |
| Bank of New York Mellon Corp | 120,634 | $3.88M | 0.00% | −550−0.5% | Reduced |
| Morgan Stanley | 120,857 | $3.88M | 0.00% | +5,323+4.6% | Added |
| Wedge Capital Management L L P | 129,755 | $4.17M | 0.07% | +129,755 | New |
| Northern Trust Corp | 136,779 | $4.40M | 0.00% | +845+0.6% | Added |
| Balyasny Asset Management LLC | 138,949 | $4.47M | 0.02% | +138,949 | New |
| Geode Capital Management, LLC | 228,792 | $7.35M | 0.00% | −3,053−1.3% | Reduced |
| Rubric Capital Management LP | 287,046 | $9.23M | 0.46% | +204,602+248.2% | Added |
| Ameriprise Financial Inc | 306,210 | $9.84M | 0.00% | +2,702+0.9% | Added |
| AIGH Capital Management LLC | 314,406 | $10.1M | 3.98% | +69,906+28.6% | Added |
| Emerald Mutual Fund Advisers Trust | 338,398 | $10.9M | 0.69% | −18,467−5.2% | Reduced |
| Kennedy Capital Management, Inc. | 342,450 | $11.0M | 0.32% | +180,376+111.3% | Added |
| First Wilshire Securities Management Inc | 367,326 | $11.8M | 4.78% | −428−0.1% | Reduced |
| Thompson Siegel & Walmsley LLC | 415,962 | $13.4M | 0.23% | −19,911−4.6% | Reduced |
| Global Alpha Capital Management Ltd. | 419,331 | $13.5M | 1.35% | +95,600+29.5% | Added |
| State Street Corp | 453,480 | $14.6M | 0.00% | −12,244−2.6% | Reduced |
| Emerald Advisers, LLC | 456,748 | $14.7M | 0.76% | +868+0.2% | Added |
| Dimensional Fund Advisors LP | 525,449 | $16.9M | 0.01% | −13,294−2.5% | Reduced |
| William Blair Investment Management, LLC | 547,389 | $17.6M | 0.07% | −9,665−1.7% | Reduced |
| Vanguard Group Inc | 787,923 | $25.3M | 0.00% | −26,251−3.2% | Reduced |
| BlackRock Inc. | 1,925,102 | $61.9M | 0.00% | −53,391−2.7% | Reduced |
| Federated Hermes, Inc. | 8 | – | – | −13−61.9% | Reduced |
| Fuller & Thaler Asset Management, Inc. | 0 | $0 | 0.00% | −46,658−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −28,800−100.0% | Sold out |
| Collective Family Office LLC | 0 | $0 | 0.00% | −7,182−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,677−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −721−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −640−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| ACG Wealth | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Sageworth Trust Co of South Dakota | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |